GOLDMAN SACHS GROUP INC - PEAR THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 65 filers reported holding PEAR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.48 and the average weighting 0.6%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$7,790
-79.9%
30,549
-7.1%
0.00%–
Q4 2022$38,797
-50.9%
32,879
+110.5%
0.00%–
Q1 2022$79,000–15,620–0.00%–
 Download
Other shareholders
PEAR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Roble, Belko & Company, Inc 4,502$00.00%
View complete list of PEAR THERAPEUTICS INC shareholders